Syntara Ltd

AU:SNT Australia Drug Manufacturers - Specialty & Generic
Market Cap
$31.35 Million
AU$50.62 Million AUD
Market Cap Rank
#24655 Global
#511 in Australia
Share Price
AU$0.03
Change (1 day)
+3.33%
52-Week Range
AU$0.02 - AU$0.08
All Time High
AU$0.40
Categories
Companies in Australia Drug Manufacturers - Specialty & Generic
About

Syntara Limited operates as a clinical-stage drug development company that targets extracellular matrix dysfunction through amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis in Australia. Its lead product candidate, amsulostat, is being developed for the treatment of bone marrow cancer myelofibrosis and i… Read more

Syntara Ltd (SNT) - Net Assets

Latest net assets as of June 2025: AU$16.02 Million AUD

Based on the latest financial reports, Syntara Ltd (SNT) has net assets worth AU$16.02 Million AUD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$21.44 Million) and total liabilities (AU$5.42 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$16.02 Million
% of Total Assets 74.7%
Annual Growth Rate -2.69%
5-Year Change 463.02%
10-Year Change -23.45%
Growth Volatility 104.67

Syntara Ltd - Net Assets Trend (2003–2025)

This chart illustrates how Syntara Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Syntara Ltd (2003–2025)

The table below shows the annual net assets of Syntara Ltd from 2003 to 2025.

Year Net Assets Change
2025-06-30 AU$16.02 Million +242.26%
2024-06-30 AU$4.68 Million -51.04%
2023-06-30 AU$9.56 Million -11.52%
2022-06-30 AU$10.80 Million +279.75%
2021-06-30 AU$2.85 Million +98.81%
2020-06-30 AU$1.43 Million -90.34%
2019-06-30 AU$14.81 Million +33.24%
2018-06-30 AU$11.12 Million +215.76%
2017-06-30 AU$3.52 Million -83.17%
2016-06-30 AU$20.93 Million -42.39%
2015-06-30 AU$36.32 Million +101.04%
2014-06-30 AU$18.07 Million -73.39%
2013-06-30 AU$67.89 Million -38.17%
2012-06-30 AU$109.80 Million +55.02%
2011-06-30 AU$70.83 Million -38.42%
2010-06-30 AU$115.02 Million -16.47%
2009-06-30 AU$137.69 Million +15.59%
2008-06-30 AU$119.12 Million +55.59%
2007-06-30 AU$76.56 Million -22.58%
2006-06-30 AU$98.89 Million +178.02%
2005-06-30 AU$35.57 Million +32.82%
2004-06-30 AU$26.78 Million -8.26%
2003-06-30 AU$29.19 Million --

Equity Component Analysis

This analysis shows how different components contribute to Syntara Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 40209853200.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$417.88 Million 2608.83%
Other Comprehensive Income AU$3.15 Million 19.65%
Total Equity AU$16.02 Million 100.00%

Syntara Ltd Competitors by Market Cap

The table below lists competitors of Syntara Ltd ranked by their market capitalization.

Company Market Cap
Companhia de Gás de São Paulo - COMGÁS
SA:CGAS3
 		$23.96 Million
The Farmers Bank of Appomattox
OTCQB:FBPA
 		$23.97 Million
Hep Tech Co Ltd
TWO:3609
 		$23.97 Million
Deniz Gayrimenkul Yatirim Ortakligi AS
IS:DZGYO
 		$23.99 Million
Cipherlab Co Ltd
TWO:6160
 		$23.95 Million
TERACT EO 1
F:6O8
 		$23.95 Million
SPSoft Inc.
KQ:443670
 		$23.95 Million
Highlands REIT Inc
OTCGREY:HHDS
 		$23.95 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Syntara Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 4,680,000 to 16,018,000, a change of 11,338,000 (242.3%).
  • Net loss of 7,919,000 reduced equity.
  • Share repurchases of 1,350,000 reduced equity.
  • Other comprehensive income increased equity by 3,148,000.
  • Other factors increased equity by 17,459,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$-7.92 Million -49.44%
Share Repurchases AU$1.35 Million -8.43%
Other Comprehensive Income AU$3.15 Million +19.65%
Other Changes AU$17.46 Million +109.0%
Total Change AU$- 242.26%

Book Value vs Market Value Analysis

This analysis compares Syntara Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.84x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.11x to 2.84x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2003-06-30 AU$0.28 AU$0.03 x
2004-06-30 AU$0.28 AU$0.03 x
2005-06-30 AU$0.27 AU$0.03 x
2006-06-30 AU$0.59 AU$0.03 x
2007-06-30 AU$0.41 AU$0.03 x
2008-06-30 AU$0.60 AU$0.03 x
2009-06-30 AU$0.67 AU$0.03 x
2010-06-30 AU$0.50 AU$0.03 x
2011-06-30 AU$0.30 AU$0.03 x
2012-06-30 AU$0.40 AU$0.03 x
2013-06-30 AU$0.22 AU$0.03 x
2014-06-30 AU$0.06 AU$0.03 x
2015-06-30 AU$0.12 AU$0.03 x
2016-06-30 AU$0.07 AU$0.03 x
2017-06-30 AU$0.01 AU$0.03 x
2018-06-30 AU$0.03 AU$0.03 x
2019-06-30 AU$0.04 AU$0.03 x
2020-06-30 AU$0.00 AU$0.03 x
2021-06-30 AU$0.01 AU$0.03 x
2022-06-30 AU$0.02 AU$0.03 x
2023-06-30 AU$0.01 AU$0.03 x
2024-06-30 AU$0.00 AU$0.03 x
2025-06-30 AU$0.01 AU$0.03 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Syntara Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -49.44%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -105.87%
  • • Asset Turnover: 0.35x
  • • Equity Multiplier: 1.34x
  • Recent ROE (-49.44%) is above the historical average (-124.10%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2003 -5.03% -3541.88% 0.00x 1.02x AU$-4.39 Million
2004 -22.41% 0.00% 0.00x 1.06x AU$-8.68 Million
2005 -28.77% -2046471.40% 0.00x 1.07x AU$-13.79 Million
2006 -17.93% -221662.50% 0.00x 1.05x AU$-27.62 Million
2007 -31.58% -1025.84% 0.03x 1.08x AU$-31.83 Million
2008 -17.16% -3878.56% 0.00x 1.05x AU$-32.35 Million
2009 -25.54% -3431.32% 0.01x 1.19x AU$-48.94 Million
2010 -40.29% -3961.11% 0.01x 1.22x AU$-57.85 Million
2011 -64.60% -3806.82% 0.01x 1.34x AU$-52.84 Million
2012 -35.19% -2636.02% 0.01x 1.20x AU$-49.62 Million
2013 -64.12% -1344.98% 0.03x 1.65x AU$-50.33 Million
2014 -286.81% -1028.95% 0.08x 3.69x AU$-53.62 Million
2015 50.84% 31.98% 0.70x 2.27x AU$14.83 Million
2016 -78.67% -114.84% 0.22x 3.14x AU$-18.56 Million
2017 -521.05% -138.09% 0.29x 12.90x AU$-18.70 Million
2018 57.82% 88.27% 0.15x 4.51x AU$5.32 Million
2019 -135.40% -353.38% 0.11x 3.56x AU$-21.54 Million
2020 -974.35% -198.42% 0.20x 24.75x AU$-14.09 Million
2021 -104.39% -39.99% 0.22x 11.81x AU$-3.25 Million
2022 -17.92% -33.58% 0.23x 2.33x AU$-3.02 Million
2023 -118.84% -197.05% 0.24x 2.51x AU$-12.32 Million
2024 -323.55% -278.96% 0.52x 2.22x AU$-15.61 Million
2025 -49.44% -105.87% 0.35x 1.34x AU$-9.52 Million

Industry Comparison

This section compares Syntara Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $19,254,961
  • Average return on equity (ROE) among peers: -149.52%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Syntara Ltd (SNT) AU$16.02 Million -5.03% 0.34x $23.95 Million
Aft Pharmaceuticals Ltd (AFP) $28.23 Million -47.00% 1.31x $53.97 Million
Althea Group Holdings Ltd (AGH) $42.70 Million -35.24% 0.26x $6.03 Million
BOD Science Ltd (BOD) $3.47 Million -155.95% 0.53x $1.38 Million
BPH Global Ltd (BP8) $-1.46 Million 0.00% 0.00x $781.31K
Cann Group Ltd (CAN) $-2.77 Million 0.00% 0.00x $2.39 Million
ECS Botanics Holdings Ltd (ECS) $188.48K -116.04% 0.13x $2.73 Million
IDT Australia Ltd (IDT) $25.01 Million -24.32% 0.25x $8.48 Million
Invion Ltd (IVX) $19.58 Million -11.45% 0.02x $2.48 Million
Little Green Pharma Ltd (LGP) $77.26 Million -10.55% 0.12x $14.26 Million
Live Verdure Ltd (LV1) $362.12K -1094.69% 2.55x $28.27 Million